Aligos Therapeutics, Inc. — SCHEDULE 13G/A Filings
8 SCHEDULE 13G/A filings on record
This page lists all SCHEDULE 13G/A filings submitted to the SEC by Aligos Therapeutics, Inc. (ALGS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Aligos Therapeutics, Inc. has filed 8 SCHEDULE 13G/A documents with the SEC since 2020. To view all SEC filings by Aligos Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
3
4
424B3
424B4
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000902664-26-001065 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001214659-26-001502 | Feb 11, 2026 | — |
| SCHEDULE 13G/A | — | 0000902664-25-005026 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-003590 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-003496 | Aug 12, 2025 | — |
| SCHEDULE 13G/A | — | 0000935836-25-000358 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-001230 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-000862 | Feb 12, 2025 | — |